Life-saving PTMC for critical calcific mitral stenosis in cardiogenic shock with balloon impasse

Dugal, J S; Jetley, V; Sabharwal, JS; Sofat, Sunil; Singh, Charanjit

doi:10.1080/14628840310017401

Cited by 3 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given its less invasive and less risky profile compared to open surgery, MBV could be an interesting option in patients with severe MS and CS or acute decompensated HF. Mostly case reports and small studies to date have evaluated the safety and feasibility of this hypothesis, where MBV has been shown to be safe and feasible in the acute management of CS, providing immediate hemodynamic and symptomatic improvement [ 71 , 72 , 73 , 74 ], even in patients during pregnancy [ 75 ]. More recently, given the emergence of transcatheter-delivered prosthetic mitral valves, the role of TMVR in the emergent setting seems promising as an alternative to surgery.…”

Section: Urgent Transcatheter Interventions For Mitral Pathologiesmentioning

confidence: 99%

Transcatheter Structural Heart Interventions in the Acute Setting: An Emerging Indication

Pyrpyris,

Dimitriadis,

Theofilis

et al. 2024

JCM

View full text Add to dashboard Cite

Structural heart disease is increasingly prevalent in the general population, especially in patients of increased age. Recent advances in transcatheter structural heart interventions have gained a significant following and are now considered a mainstay option for managing stable valvular disease. However, the concept of transcatheter interventions has also been tested in acute settings by several investigators, especially in cases where valvular disease comes as a result of acute ischemia or in the context of acute decompensated heart failure. Tested interventions include both the mitral and aortic valve, mostly evaluating mitral transcatheter edge-to-edge repair and transcatheter aortic valve implantation, respectively. This review is going to focus on the use of acute structural heart interventions in the emergent setting, and it will delineate the available data and provide a meaningful discussion on the optimal patient phenotype and future directions of the field.

show abstract

Section: Urgent Transcatheter Interventions For Mitral Pathologiesmentioning

confidence: 99%

Transcatheter Structural Heart Interventions in the Acute Setting: An Emerging Indication

Pyrpyris,

Dimitriadis,

Theofilis

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

Rheumatic Mineralization of Aortic Valve and Anterior Mitral Leaflet—A Case Report

Muthiah¹

2017

CRCM

View full text Add to dashboard Cite

Aim: To present the heterotopic ossification of left-sided heart valves due to rheumatic inflammation and biomineralization. Introduction: Calcification in the region of mitral-aortic continuity is significant at its origin and etiopathogenesis. The etiology of valvular calcification may be divided into 3 groups, namely, inflammation, degeneration and metabolic disturbances. Calcification of cardiac valve leaflets is most often due to rheumatic etiology in tropical nations. Case Report: A 52-year-old male developed sudden onset of light-headedness and palpitations due to atrial fibrillation. Transthoracic 2D echocardiography revealed calcification of anterior mitral leaflet and aortic valve which resembles a bone-like structure and the patient was advised double valve replacement. Conclusion: It was known that the cellular mechanisms play an important role in its genesis and therapeutic strategies are targeted to reverse this process by understanding its biological mediators.

show abstract

Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the Association for Acute Cardiovascular Care (ACVC) and the ESC Working Group on Cardiovascular Surgery

Fraccaro,

Karam,

Möllmann

et al. 2023

EuroIntervention

View full text Add to dashboard Cite

Valvular heart disease (VHD) is one of the most frequent causes of heart failure (HF) and is associated with poor prognosis, particularly among patients with conservative management. The development and improvement of catheter-based VHD interventions have broadened the indications for transcatheter valve interventions from inoperable/high-risk patients to younger/lower-risk patients. Cardiogenic shock (CS) associated with severe VHD is a clinical condition with a very high risk of mortality for which surgical treatment is often deemed a prohibitive risk. Transcatheter valve interventions might be a promising alternative in this setting given that they are less invasive. However, supportive scientific evidence is scarce and often limited to small case series. Current guidelines on VHD do not contain specific recommendations on how to manage patients with both VHD and CS. The purpose of this clinical consensus statement, developed by a group of international experts invited by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Scientific Documents and Initiatives Committee, is to perform a review of the available scientific evidence on the management of CS associated with left-sided VHD and to provide a rationale and practical approach for the application of transcatheter valve interventions in this specific clinical setting.

show abstract

Life-saving PTMC for critical calcific mitral stenosis in cardiogenic shock with balloon impasse

Cited by 3 publications

References 10 publications

Transcatheter Structural Heart Interventions in the Acute Setting: An Emerging Indication

Transcatheter Structural Heart Interventions in the Acute Setting: An Emerging Indication

Rheumatic Mineralization of Aortic Valve and Anterior Mitral Leaflet—A Case Report

Contact Info

Product

Resources

About